The United States (US) Department of Veterans Affairs (VA) Mid-Atlantic Mental Illness Research, Education, and Clinical Center (MIRECC) Post-Deployment Mental Health (PDMH) multi-site study examines post-deployment mental health in US military Afghanistan/Iraq-era veterans. The study includes the comprehensive behavioral health characterization of over 3600 study participants and the genetic, metabolomic, neurocognitive, and neuroimaging data for many of the participants. The study design also incorporates an infrastructure for a data repository to re-contact participants for follow-up studies. The overwhelming majority (94%) of participants consented to be re-contacted for future studies, and our recently completed feasibility study indicates that 73-83% of these participants could be reached successfully for enrollment into longitudinal follow-up investigations. Longitudinal concurrent cohort follow-up studies will be conducted (5-10+ years post-baseline) to examine predictors of illness chronicity, resilience, recovery, functional outcome, and other variables, and will include neuroimaging, genetic/ epigenetic, serum biomarker, and neurocognitive studies, among others. To date, the PDMH study has generated more than 35 publications from the baseline data and the repository has been leveraged in over 20 publications from follow-up studies drawing from this cohort. Limitations that may affect data collection for a longitudinal follow-up study are also presented.
among the top three diagnoses of veterans obtaining VA care, with approximately 57.6% having at least one mental health diagnosis.
The most prevalent mental health diagnoses were posttraumatic stress disorder (PTSD; 55%), depressive disorders (45%), anxiety (43%), and alcohol dependence (13%; Epidemiology Program et al., 2015) .
Much remains to be learned about whether and how postdeployment mental health may be a function of genetic or biopsychosocial risk and resilience factors combined with the stress and trauma of combat or war-zone exposure. Work is needed to (1) develop post-deployment mental illness phenotypes across biological, clinical, and behavioral traits; (2) examine variations in critical genes, proteins, neurosteroids or other small molecules, brain structures, epigenetic, mRNA, and other biological data within symptom clusters and phenotypes identified to be pathognomonic for mental illness; (3) understand the relationship between pre-military/pre-deployment mental health and biological factors and post-deployment mental health conditions; (4) understand associated health and health risk behaviors for this particular cohort; (5) identify health care service utilization and outcomes for this cohort and subgroups within this cohort; (6) update psychometric properties of mental health assessments utilized with this cohort; and (7) examine gender differences and similarities in the etiology and manifestation of mental health conditions and associated health sequelae. Above all, there remains tremendous unmet demand for developing effective, evidence-based assessment and treatment options.
Iraq-and Afghanistan-era veterans report deployment experiences that are distinct from veterans who served in prior eras. These differences include an all-volunteer military, multiple combat deployments, a high percentage of women and parents of young children, and a high number of veterans who have sustained severe injuries that would have resulted in death in previous wars (Institute of Medicine, 2013) . The need for a substantial infrastructure to facilitate comprehensive and broad-based research programs that investigate the behavioral and medical health needs of this cohort quickly became apparent.
| Objectives
The study of Post-Deployment Mental Health (PDMH), developed and funded by the VA Mid-Atlantic Mental Illness Research, Education and Clinical Center (MIRECC), was established in 2005 as a comprehensive multi-site regional mechanism to create such a research infrastructure.
The study had two primary goals. First, it was to serve as a baseline study to characterize mental health risk and resiliency factors in these veterans. The second goal was to create a data repository to serve as (a) a central "subject registry" or re-contact database and (b) a "data warehouse". The "subject registry" would collect and store contact information of participants who consented to be recruited for additional follow-up research studies. The "data warehouse" would store data collected from the baseline as well as other follow-up studies of the same participants. The intent of the PDMH baseline study was to address the gaps in research noted earlier. This extensive multi-site effort now houses one of the most comprehensive, large, planned databases of post-9/11 US veterans currently available for collaborative research endeavors. The purpose of this paper is to describe its design and methodology, enumerate its strengths and limitations, and communicate the challenges of establishing a large repository of multi-site data. 
| Study population
Inclusion criterion entailed serving in the US military (i.e. veterans, active-duty personnel), and/or reserve forces (National Guard members and Reservists) on or after . Exclusion criteria included primary language other than English, difficulty comprehending the informed consent form or process, and/or inability to travel to one of the participating data-collection sites. Neither deployment nor health care treatment-seeking were required for study enrollment.
| Study recruitment
Participants were recruited through mailings (all VA patients who met criteria), advertisements, and VA clinician referrals. The combination of recruitment methods produced a purposive convenience sample of individuals largely served by the VA medical centers in the Mid-Atlantic region of the US. Participants verbally confirmed their period of military service during an initial phone screening prior to participation and verified service status with a copy of their military service documentation form at enrollment into the study. Starting in 2015, recruitment was modified to oversample women for baseline and follow-up studies. A target goal of recruiting 67% women was set for each site in order meet a target goal of 1000 female veteran participants by 2017.
| Enrollment and informed consent
The PDMH study protocol was approved by the Durham VAMC Institutional Review Board (IRB) and subsequently approved by local review boards of each participating site. Each enrolled study participant was asked to separately consent to baseline data collection and to repository data collection. Written informed consent specifically requested permission to (1) use blood samples for DNA/RNA analyses, protein characterization, neurosteroid, and other small molecule analyses; (2) retrieve health care information from VA electronic medical records; (3) contact a friend or family member in the event that he/ she could not be reached for future studies or for emergencies; and (4) add blood, questionnaire data, neuroimaging, contact information (for him/herself and friend/family member), and/or medical record information to a repository for future analyses or follow-up studies.
Participants were provided the opportunity to consent or decline consent/access for each of these items separately. Table 1 and the Methods section describe the data collected for the baseline study. For repository data collection, participants who consented had their baseline data and contact information added to the data repository. Researchers interested in further investigating various mechanisms among target populations could subsequently select participants based on the data collected to recruit into follow-up studies (see Appendix Table A1 ).
Participants were compensated $175 for completion of the fullday study (prorated for partial completion) plus a travel stipend based on distance traveled (between $8-$75 for 25-200+ miles).
| Data collection and management procedures
Initially data were collected via paper-and-pencil forms using doubleentry techniques for data capture. Following the first year, a website was developed that allowed participants and study staff to enter study data directly into a back-end Microsoft Structured Query Language (SQL) Server Database. The system was developed to reduce human data entry errors and increase efficiency. The website featured data validation and skip-pattern logic to ensure that study data were collected as accurately as possible. The website interface could be accessed simultaneously by both participants and study staff. This arrangement allowed study staff to concurrently review questionnaires for completeness, as well as to provide alerts regarding potential for risk-of-harm questionnaire items (e.g. suicidal ideation) that may require study clinician risk assessment follow-up (Brown, Strauss, et al., 2014) . Participants were made aware of these features prior to participating in the study. 
| Medical history and medications
Participants were asked to complete a medical questionnaire that was also used by the National Vietnam Veterans Readjustment Study (NVVRS; Kulka et al., 1990) . Information also included prescription and non-prescription medications, dose, and length of use. Objective medical service utilization and laboratory data values are planned to be retrieved from medical record data for participants who used VA health care services. The Corporate Data Warehouse (CDW) will be accessed for this purpose. The CDW contains data on every outpatient and inpatient visit by a veteran to a VA community clinic or medical center. The CDW also contains data on every outpatient medication dispensed to a veteran by any VA facility. In addition to objective measures of health service utilization, the CDW contains validated patient reported outcomes, such as the Alcohol Use Disorders Identification Test (AUDIT-C), an alcohol screen for misuse, and may contain multiple data points for measures administered at more than one patient visit.
| Blood and serum samples
Blood samples were obtained between 10:30 a.m. and 2:30 p.m. via venipuncture by a member of the research team trained in phlebotomy. Blood samples from collaborating sites were transported to the main storage site (Durham VAMC) by vehicle or certified shipping on dry ice. All blood was stored in ˗80°C freezers until analyzed. Blood was allocated for DNA extraction and analysis, mRNA and epigenetic studies, and serum investigations of neurosteroids, other small molecules, and proteins to investigate possible biomarker candidates for psychiatric disorders and therapeutic targets. Genomic DNA was extracted from peripheral blood samples via alcohol and salt precipitation using Gentra Systems PUREGENE DNA Purification kit (Qiagen, Valencia, CA) . Neurosteroid levels in sera were determined by a highly sensitive and specific gas chromatography/mass spectrometry (GC/MS) method. The limit of detection for this MS method was 1-2 pg for each neurosteroid . Various analyses including neurosteroid, whole-genome and other genotyping are described in further detail elsewhere (e.g. Ashley-Koch et al., 2015; Kimbrel, Hauser, et al., 2015; Liu et al., 2015; Marx et al., 2015; Naylor et al., 2015; Naylor, Kilts, Szabo, Dunn, Keefe, et al., 2016 ).
| Self-administered questionnaires
Participants completed self-reported measures of various psychological and neuropsychiatric symptoms and medical conditions (see Table 1 ). Questionnaires were administered in a randomized order, 
| Clinician-administered interviews and questionnaires
The Structured Clinical Interview for DSM-IV-TR Axis-I Disorders (SCID-I; First et al., 1994) , a semi-structured interview guide, was used to determine DSM-IV Axis I diagnoses. The SCID has been found to be both clinically sensitive and reliable (Keane & Barlow, 2002) , with good to excellent interrater reliability for current disorders and moderate test-retest reliability for lifetime disorders (Rogers, 2001) . Both lifetime and current psychiatric diagnoses and symptom-level data were collected. All interviewers completed the recommended SCID training program (watching training tapes, observing, being observed and rated with feedback). Interviewers have demonstrated excellent mean interrater reliability for any Axis I diagnoses (Fleiss' kappa = 0.94), and specifically for current PTSD (Fleiss' kappa = 1.0). Given that this was a multi-site study, the biggest challenge faced was the potential for rater drift. This was addressed by requiring all study interviewers to attend biweekly peer consultation, supervised by a licensed psychologist. Additional annual rater observations were conducted to evaluate rater drift. In 2010, data collection transitioned to the electronic SCID (eSCID). Interview method was unchanged but used electronic data capture instead of paper and pencil to reduce data entry errors.
Several eSCID skip patterns were modified to ensure a more complete administration of the most common psychiatric disorders among this cohort. The PTSD section was reconfigured to be administered first, prior to other anxiety disorders. As the most prevalent diagnosis among this cohort, ruling out PTSD before assessing other anxiety disorders was most efficient and evidence-based. Additionally, all PTSD items were administered without skip-outs, and regardless of whether DSM-IV criterion A2 (fear, helplessness, or horror in response to trauma exposure) or symptom clusters were fully endorsed. This supported early recognition that veterans did not always endorse experiencing "fear, helplessness, or horror". The purpose of administering all symptom items would allow future evaluation of subthreshold PTSD symptoms (Brancu et al., 2016) , which can also cause significant impairment and warrants further research. additional war zone experiences were added to expand knowledge in those emerging areas (see Table 1 for these measures and when they were added). The moral injury and spirituality measure, Modified Brief
| Neuroimaging
Multidimensional Measure of Religiousness/Spirituality (M-BMMRS;
see Table 1 ), was developed specifically to evaluate the most critical and basic religious/spiritual demographics and topics that had previously been published as important to attend to among veterans with PTSD.
In 2010, four DSM-5-related PTSD questions were also added to supplement the DSM-IV SCID-I interview (see Supporting Information). These four questions were developed in response to proposed changes to the DSM-5 PTSD criteria and prior to the actual publication of DSM-5 in 2013. These items were based on early proposals for the Clinician-Administered PTSD Scale for DSM-5 (CAPS-5; Weathers et al., 2013) , though developed prior to the new CAPS-5 scale being released. The questions were reviewed and piloted by SCID interviewers as well as by internal and external PTSD subject matter experts. While criteria A2 ("fear, helplessness, or horror" experience) and criterion C "foreshortened future" were no longer part of the DSM-5 diagnosis, the items were nevertheless kept as part of administration for both the purpose of consistency and to allow greatest flexibility with changing scoring rubrics. The change to criterion C "avoidance cluster" was determined not to be a significant change to warrant revision to current administration. The study team also added a specifier of "self, other, both" based on the knowledge that the new negative cognitions symptoms could refer to self and/or others, which would be useful data for pre-post screening for follow-up evidence-based psychotherapy study trials. Since the data collection method required full administration of all SCID PTSD items, scoring could essentially be programmed to evaluate (a) DSM-IV PTSD, (b) a reasonable approximation to DSM-5 PTSD, and (c) various subthreshold levels of PTSD using different algorithms of cluster and symptom endorsements.
Measures of PTSD-related functioning (CAPS-Global Functioning
Questions [GFQ]; Blake et al., 1995) and an internally developed clinician-administered traumatic brain injury (TBI) interview were also added, the latter to better operationalize severity of TBI according to the American Congress of Rehabilitation Medicine criteria (Menon, Schwab, Wright, & Maas, 2010 ) (see Table 1 and Supporting Information).
| Publishing during long-term ongoing data collection
A significant challenge for any long-term study is how to handle publishing during data collection. Procedures were implemented to develop a "production" database in which data were added during enrollment at planned intervals, and a "research" database where cleaned data were deposited. Data cleaning occurred immediately if a new problem was identified that would lead to analysis problems but would otherwise be slated for yearly cleaning. Upon yearly cleaning, the new dataset was considered to be "locked down" and with few exceptions, only the locked down datasets were made available for analyses. The electronic data gathering system also allowed datestamping and tracking of changes in case there were questions about cleaning corrections. Table 2 ). Most veterans (91%) were discharged from the military honorably, served in the Army (65%), were enlisted rank (92%), and served in a war zone (79%). Approximately 8.5% of the participants were active duty military service members and nearly one-third also served in the Reserves or National Guard. Nearly half of the cohort had served in the military prior to the post-9/11 era, including some who also served during the First Persian Gulf War and other previous eras (see Table 3 ).
Approximately half of the cohort reported receiving outpatient mental health treatment either within and/or outside the VA system. Slightly more than half had at least one medical condition diagnosed by a physician, and more than half had a disability for which the individual was receiving VA benefits ("service connected disability") ( Table 2 ).
Approximately 22% met criteria for current major depressive disorder (MDD; 42% met criteria for lifetime MDD), 26% met current PTSD criteria (37% lifetime), 15% of the total sample had both current PTSD and MDD, 6% met criteria for current alcohol abuse and/or dependence (37% lifetime), and 1.5% met criteria for cannabis abuse/ dependence (10% lifetime). Twenty-one percent endorsed at least one deployment-related TBI (per MIRECC TBI interview) (See Table 4 for complete details about clinical presentation). Mean number of lifetime traumatic events experienced (Table 5) 
| Published findings
The PDMH study is an open ongoing study that is completing baseline data collection as it transitions to a longitudinal study. Thus, reported findings are still considered to be preliminary analyses of subsets of the data as we continue to collect sufficient data for certain subsamples. For a study that has been collecting data for over 10 years, the purpose of continuously publishing preliminary findings is to share important findings with the broader public, to support ongoing research, and for pre-decisional efforts to formulate future potential policy recommendations. Once sufficient data are collected, information will be shared with the VA that may help with developing or formulating policies to improve post-deployment mental health care.
More than 35 manuscripts of preliminary analyses of subsets of data have been published from data acquired by the PDMH study (Appendix Table A2 ) and 20 manuscripts published from PDMH follow-up and longitudinal cohort studies (Appendix Table A1 ).
3.3 | Retention efforts 3.3.1 | Additional sub-studies of the PDMH study cohort
As a result of the infrastructure developed to maintain a data repository, more than 25 IRB-approved studies have recruited or are currently recruiting participants from the re-contact database of the repository for genetic, epigenetic, gene expression, metabolomic, Preliminary information gathered from a number of these studies suggests success in recruiting this cohort for longitudinal followups, as follows: (1) large numbers of participants have been recruited into additional sub-studies (e.g. neuroimaging study n > 485; neurocognitive study n > 425); (2) 73% of eligible participants in an imaging genetics sub-study and 89% of a magnetoencephalography (MEG) sub-study were able to be recruited using telephone contact information only, with no further contact attempts (e.g. mailed letters); and (3) a neurocognitive sub-study has thus far been able to meet over 85% of its recruitment goal (out of a planned 500)
recruiting from the repository.
| Pilot study to test feasibility of longitudinal follow-up
At Year 10, a pilot study of a small randomized subsample of the full cohort was conducted to examine the feasibility of conducting a longitudinal follow-up of this cohort. The Dillman Total Design Method (Hoddinott & Bass, 1986) was used as the model for re-contacting 100 baseline PDMH study participants who had consented to re-contact for future studies. The 100 participants were randomized and broken down to an equal number across three approximately 3-year cohorts (first 3-4 years, next 3 years, and most recent 3 years of recruitment), and also balanced to reflect 50% male and 50% female.
The purpose of this stratification was to determine whether recruitment of certain years or by female gender would pose any differential challenges. Four attempts were made to contact each participant, followed by four attempts to contact the participant's friend/kin if direct contact failed. Initial contacts were by mail and included the option of opting out of future contact if desired. Participants and/or kin were also contacted by telephone two weeks after the second mailing was sent.
Overall, 91% of the sample was located (25% by mail only, the remaining by telephone calls and medical record review). After 7% attrition (due to death, incarceration, desire to no longer be contacted, or multiple failed missed connections), 83% of the 100 participants provided updated contact information and expressed interest in ongoing contact for a future follow-up study.
| Full mail-out
At Year 9 of the study, a retention check was conducted by sending out a letter, using the Dillman Method, to all prior study participants to evaluate the accuracy of contact records. Of the 3037 letters mailed, 674 (22%) were sent back due to an incorrect or outdated address, highlighting the need to use telephone and other methods to reach participants.
| DISCUSSION
The PDMH study was one of the earliest to comprehensively assess example related study), among others. It is also one of the few studies that includes a SCID assessment, blood draw, and original consent to re-contact participants for future studies. With data collected on over 3600 Iraq/Afghanistan-era veterans, over 94% of whom originally agreed to be re-contacted, and a randomized feasibility pilot demonstrating 83% interest in participating in a longitudinal follow-up study, perhaps the most unique contribution is the robust research infrastructure to support future longitudinal follow-ups of the total cohort. It also demonstrates our ability to support large-scale worldwide Lifetime n/a n/a n/a n/a n/a n/a Lifetime n/a n/a n/a n/a n/a n/a collaborative genomic study efforts of similar studies to better understand the genomic architecture of conditions such as PTSD (Ripke et al., 2014; Logue et al., 2015) .
Several methodological strengths include: (1) capturing a wide range of information including genome-wide association studies (GWAS) and methylation on all of the samples allowing for genetic and epigenetic effects, metabolomic, proteomic, transcriptomic, neuroimaging, clinical, and behavioral data to evaluate cutting edge biological mechanisms and therapeutic candidates, (2) plans to connect this information with health care utilization data to better understand risk and protective factors affecting health care outcomes, (3) long-term efforts to prevent rater drift and ensure reliability of diagnostic assessments, and (4) development and implementation of an electronic system to reduce data-entry errors. The use of semi-structured clinical interviews for psychiatric diagnosis is also a significant strength, as most large studies that have examined mental health diagnoses have relied on medical chart diagnoses or screens that may introduce significant biases, false-positive rates, and other errors. Additionally, the repository has successfully supported recruitment for over 25 additional follow-up studies, with data from those studies planned for integration into the current database to further expand all possible future analyses.
Recently, the GWAS, neuroimaging, and neurosteroid and small molecule data have also begun to be combined into several biomarker analyses. While some of these efforts have been undertaken with other cohorts, this is the only study we are aware of for which all of these methods have been pursued in concert with this particular cohort of veterans to create such a comprehensive data repository. This comprehensive repository has already led to a number of important advancements in clinical practice and will continue to do so as it expands. This includes clinical trials testing pharmacological interventions to treat TBI , subthreshold PTSD (Naylor et al., 2013) , and PTSD resistant to antidepressants ; development of violence risk assessment measures (Elbogen et al., 2013; Elbogen et al., 2014) ; identification of white matter alterations that occur after blast exposure without acuteTBI symptoms (Taber et al., 2015) ; performance of screening tools for hazardous alcohol use Crawford et al., 2013) Demographic strengths include successful recruitment of a sample containing a high percentage of women (20%) and African Americans (nearly 50%), those receiving VA benefits through a service-connected disability (57%), war zone exposure (79%), service in past eras (nearly 50%), mental health conditions (approximately 50%), and TBI (21%).
These large subgroups will support follow-up studies evaluating between-group comparisons of post-deployment mental health trajectories.
| Limitations of the study design
A limitation is that the study participants comprise a large convenience sample of post-9/11 service members who live in the Mid-Atlantic region of the country, many of whom are receiving health care services through the VA, rather than a representative sample of the US veteran population. This is not necessarily a limitation for the current study, however, as the purpose of this effort was not to determine prevalence rates via an epidemiological approach but rather to (a) screen conditions for follow-up recruitment studies and (b) characterize specific risk and protective factors within certain subgroups. Additionally, despite it being a convenience sample, the PDMH study demographics still closely match the demographic make-up of the US post-9/11 veteran population in age and educational attainment for both men and women. While the PDMH study cohort includes a higher percentage of non-white and unmarried veterans than the national veteran population, it nonetheless reflects the general finding that post-9/11 US veterans are more likely to be non-white and unmarried (National Center for Veterans Analysis and Statistics
[NCVAS], 2015). The PDMH study sample also matches the general finding that post-9/11 women veterans are more racially diverse, more likely to be unmarried, and more likely to hold a higher educational degree than their male colleagues (NCVAS, 2015) . (former active duty versus Reserve/National Guard) breakdowns are similar to the national VA Iraq/Afghanistan veteran health care population. Mental health diagnostic rates are similar for PTSD, depression, and alcohol abuse/dependence; however, rates are lower for other drug abuse/dependence (Epidemiology Program et al., 2015) .
While self-report validity could be a concern for certain individuals or a smaller study, we believe having a larger cohort diminishes the concerns regarding potential self-report problems by a small subgroup.
Additionally, when validity has been identified as a concern for an individual participant (e.g. inconsistencies between SCID and self-reports) those few cases were removed from future analyses. As participants may not all have the ability to provide certain medical data accurately (e.g. medications, diagnosed physical disorders), these will be checked via the medical chart data extraction. Unfortunately, a limitation to this method is lack of access to non-VA medical records.
Given our interest in examining PTSD symptom severity longitudinally, we chose to continue administering the same DSM-IV-based measure of PTSD, even after the in PTSD diagnostic criteria from DSM-IV to DSM-5. While we considered adding an entirely separate interview to measure DSM-5 criteria, we were concerned about participant burden.
Given the substantial overlap between DSM-IV and DSM-5 criteria, we chose to simply add four additional items that tap non-overlapping or significantly changed PTSD symptom criteria to the DSM-IV based interview. A potential limitation of this approach is that the interview used in this study may not be directly comparable to other standardized interviews currently being developed to assess DSM-5 PTSD. This approach could also potentially increase the correlation between DSM-IV based and DSM-5 based diagnostic assessment.
While an electronic data-entry system is a strength when it comes to reducing data-entry errors, it may also introduce unintended modifications to standard paper-and-pencil measures. A controlled comparison was not conducted to examine the effect of using a computer versus paper forms for this study. However research findings across multiple studies with different populations suggest that Web-based administration produces findings nearly identical to paper-and-pencil administration (e.g. Carlbring et al., 2007; Van de Looij-Jansen & de Wilde, 2008; Weigold, Weigold, & Russell, 2013) .
| Implications and next steps
The course and treatment of mental health issues cannot be determined in a single snapshot, but evolves over time. In developing this large PDMH cohort study, we intend to track participants longitudinally across the lifespan. In particular, we seek to (1) 
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SUPPORTING INFORMATION
Additional Supporting Information may be found online in the supporting information tab for this article. Thirty-nine veterans recently returning from Iraq and Afghanistan deployments underwent a functional magnatic resonance imaging (fMRI) scan while exposed to emotional combat-related and neutral civilian scenes interleaved with an executive processing task. Purpose was to investigate the relationship of executive and emotion-processing regions with severity of posttraumatic stress disorder (PTSD) symptoms.
To recruit a target population Hayes et al., 2011 Compared responses by 15 combat veterans diagnosed with PTSD and 14 trauma-exposed control participants to trauma-related and neutral pictures while undergoing event-related fMRI. Purpose was to examine the neural correlates of successful memory encoding. Morey, Gold, et al., 2013 Compared 99 subjects with current PTSD and 101 traumaexposed controls without PTSD using structural MRI and clinical diagnostic assessments. Purpose was to assess the effect of PTSD on volumetric changes in the amygdala and (Continues) Compared high angular resolution diffusion imaging (HARDI) of 30 subjects with mild traumatic brain injury (TBI) and comorbid PTSD and depression with non-TBI participants from primary (n = 42) and confirmatory (n = 28) control groups. Purpose was to investigate the effect of PTSD and comorbid TBI on white matter integrity. Compared resting-state fMRI scans between 20 military veterans with PTSD and 22 matched trauma-exposed controls to measure task-free synchronous blood oxygen level dependent activity. Whole-brain voxel-wise functional connectivity of basolateral and centromedial amygdala seeds was compared between groups. Purpose was to better understand PTSD differences in amygdalacomplex function and functional connectivity with cortical and subcortical structures. Taber et al., 2015 Compared 23 veterans exposed to primary blast without TBI symptoms, six exposed to primary blast with mild TBI, and 16 unexposed to blast. Purpose was to use diffusion tensor imaging to investigate white matter alterations associated with blast exposure with or without acute symptoms of TBI. Evaluated psychometric properties of the Behavioral Dyscontrol Scale (BDS) and BDS-II scoring systems. The BDS-II showed improved psychometric properties and was significantly more reliable than the BDS. Shura, Rowland, & Yoash-Gantz, 2015 Sample evaluated 164 subjects. Purpose was to evaluate the factor structure and construct validity of the BDS-II.
To recruit a target population Shura, Miskey, Rowland, Yoash-Gantz, & Denning, 2016 Compared 44 "failed-validity" and 168 "passed-validity" groups. Purpose was to evaluate the accuracy of individual embedded validity measures and to reduce them to the most efficient combination to improve comprehensive assessment of performance validity.
To recruit a target population Neurosteroids and other therapeutics Marx et al., 2009 Proof-of-concept randomized controlled trial of adjunctive pregnenolone for cognitive and negative symptoms in patients with schizophrenia or schizoaffective disorder. Randomized 21 participants.
Augment recruitment of target population Naylor et al., 2013 Proof-of-concept randomized controlled trial of paroxetine in subthreshold PTSD. Purpose was to conduct a small pilot randomized controlled trial of paroxetine for subthreshold PTSD. Randomized 13 participants.
To recruit a target population Marx et al., 2015 Proof-of-concept randomized controlled trial of a neurosteroid intervention in mild TBI and biomarker candidate study in blast-related TBI. Purpose was to examine the potential utility of neurosteroids as therapeutic interventions in TBI via a pilot proof-of-concept randomized controlled trial with adjunctive pregnenolone. Randomized 30 participants. Also see Table A2 for baseline analyses informing this trial.
To recruit a target population for intervention study Naylor et al., 2015 Proof-of-concept (childhood, combat, adult, medical) were differentially associated with the risk of different psychiatric diagnosis, comorbidity, and current symptom severity. Schry et al., 2015 Among male OEF/OIF veterans, military sexual assault (MSA) was associated with greater symptom severity and treatment support than for those without MSA, above and beyond the effects of known vulnerability factors.
Resilience and trauma Brancu et al., 2014 ; Social support does not serve as a buffer as well for those with PTSD compared with those without the disorder; however, comorbid conditions do not necessarily make this dampened buffering effect any worse. Van Voorhees et al., 2012 Childhood trauma-based PTSD, especially avoidance and numbing symptoms, were found to be related to compromised social support in adulthood. Green et al., 2010; Youssef et al., 2013a In terms of overall resilience, (a) higher levels of resilience are especially protective for those with high combat exposure (Green et al., 2010) ; (b) resilience plays a uniquely protective role in PTSD and functional correlates such as suicidality, alcohol problems, and depression (Green et al., 2010; Youssef et al., 2013a) ; and (c) childhood trauma exposures were significantly associated with depressive symptoms and suicidal ideation (Youssef et al., 2013a PTSD emotional numbing symptoms (e.g. feelings of detachment from others, restricted range of affect) were most strongly uniquely associated with suicide ideation (Guerra et al., 2010) . For those with comorbid PTSD and major depressive disorder (MDD), the numbing plus the cognitive-affective cluster of depressive symptoms (e.g. persistent depressed mood; excessive/inappropriate guilt) were related to suicidality. Further support for this finding was later presented using a 3-factor measurement model of externalizing (substance use disorders), fear (panic disorder, social phobia, specific phobia, and obsessive-compulsive disorder), and distress (PTSD and depression) factors . The distress factor in particular was significant for suicidality and suicide attempts. Vulnerability: Youssef et al., 2013a Childhood trauma exposures were found to be associated with depressive symptoms and suicidal ideation.
Violence Elbogen et al., 2010 Aggressive impulses or urges, difficulty managing anger, and perceived problems controlling violent behavior were each significantly associated with PTSD hyperarousal symptoms.
Substance use Smoking: Calhoun et al., 2011; McClernon et al., 2013 PTSD symptoms affected the expectancies veterans had regarding the benefits of smoking, including beliefs that smoking could reduce negative affect and boredom or increase social facilitation . The risk of smoking increased as a function of the number of comorbid psychiatric illnesses with similar reported expectancies (McClernon et al., 2013) suggesting that both PTSD as well as co-occurring psychiatric conditions affect smoking habits. Alcohol and other drug use: Kelley et al., 2013; Kelley et al., 2015 Depressive symptoms significantly mediated the effects of combat and noncombat exposure on both alcohol and drug use. Similarly, PTSD symptoms served as a similar mediator between trauma exposure and alcohol, but only for men and not for other drug use. PTSD symptoms did not serve as a mediator between trauma exposure and alcohol use nor drug use for women.
Pain Runnals et al., 2013 Veterans with PTSD endorsed pain-related complaints at greater rates than veterans without PTSD, and even higher rates were observed among those with comorbid PTSD/MDD. The highest rates of pain complaints were reported among those with comorbid PTSD/MDD. Women were also more likely to endorse back pain and headaches in general. Kilts et al., 2010; Naylor, Kilts, Szabo, Dunn, Keefe, et al., 2016; In a small proof-of-concept study (n = 90 males), allopregnanolone levels were found to be inversely associated with low-back pain and chest pain. DHEA levels were also inversely associated with muscle soreness and positively associated with chest pain. In a larger replication study of 485 males (Naylor, Kilts, Szabo, Dunn, Keefe, et al., 2016) , allopregnanolone levels were inversely associated with muscle soreness and chest pain. After correcting for the family-wise error rate, only muscle soreness remained significant. Allopregnanolone levels were also found to be (Continues)
